首页> 外国专利> AUTOLOGOUS SELF-TOLERANCE INDUCING CELLS MONOCYTARY ORIGIN AND ITS USE IN MEDICINAL PRODUCTS

AUTOLOGOUS SELF-TOLERANCE INDUCING CELLS MONOCYTARY ORIGIN AND ITS USE IN MEDICINAL PRODUCTS

机译:自体自耐受诱导细胞单细胞起源及其在医药产品中的应用

摘要

The invention relates to cells of monocytic origin suitable for the prevention and/or treatment of diseases associated with disturbed self-tolerance, in particular autoimmune diseases and allergies, and to pharmaceutical preparations containing these cells. The cells are autologous in relation to the patient to whom they are to be administered. The invention further relates to a process for the generation and/or, propagation of autologous regulatory T cells.
机译:本发明涉及单核细胞源的细胞,其适合于预防和/或治疗与自身耐受性紊乱有关的疾病,特别是自身免疫性疾病和变态反应,并涉及含有这些细胞的药物制剂。相对于要施用细胞的患者,细胞是自体的。本发明进一步涉及用于产生和/或繁殖自体调节性T细胞的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号